Jeffrey S Hyams (Jeffrey Hyams)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Eileen Crowley, Christopher Ma, Leonard Guizzetti, Guangyong Zou, Peter J Lewindon, Michael S Gee, Jeffrey S Hyams, Michael J Rosen, Daniel von Allmen, Anthony de Buck van Overstraeten, Lisa M Shackelton, Julie Remillard, Lauren Schleicher, Jonathan R Dillman, Jordi Rimola, Stuart A Taylor, Joel G Fletcher, Peter C Church, Brian G Feagan, Anne M Griffiths, Vipul Jairath, Mary-Louise C Greer
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials. Inflammatory bowel diseases (2023)
Ruben J Colman, Tomoyuki Mizuno, Keizo Fukushima, David B Haslam, Jeffrey S Hyams, Brendan Boyle, Joshua D Noe, Geert R A M D'Haens, Johan E Van Limbergen, Kelly Chun, Jane Yang, Lee A Denson, Nicholas J Ollberding, Alexander A Vinks, Phillip Paul Minar
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary pharmacology & therapeutics (2022)
Joelynn Dailey, Lina Kozhaya, Mikail Dogan, Dena Hopkins, Blaine Lapin, Katherine Herbst, Michael Brimacombe, Kristen Grandonico, Faith Karabacak, John Schreiber, Bruce Tsan-Liang Liang, Juan C Salazar, Derya Unutmaz, Jeffrey S Hyams
Antibody Responses to SARS-CoV-2 after Infection or Vaccination in Children and Young Adults with Inflammatory Bowel Disease. medRxiv : the preprint server for health sciences (2021)
Ruben J Colman, Ye Xiong, Tomoyuki Mizuno, Jeffrey S Hyams, Joshua D Noe, Brendan Boyle, Geert R D'Haens, Johan E Van Limbergen, Kelly Chun, Jane Yang, Michael J Rosen, Lee A Denson, Alexander A Vinks, Phillip Paul Minar
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Alimentary pharmacology & therapeutics 55 (5) (2021)
Joelynn Dailey, Lina Kozhaya, Mikail Dogan, Dena Hopkins, Blaine Lapin, Katherine Herbst, Michael Brimacombe, Kristen Grandonico, Fatih Karabacak, John Schreiber, Bruce Tsan-Liang Liang, Juan C Salazar, Derya Unutmaz, Jeffrey S Hyams
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases (2021)
Ryan C Ungaro, Liangyuan Hu, Jiayi Ji, Shikha Nayar, Subra Kugathasan, Lee A Denson, Jeffrey S Hyams, Marla C Dubinsky, Bruce E Sands, Judy H Cho
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease. Alimentary pharmacology & therapeutics 53 (2) (2020)
Julia K Carmody, Jill Plevinsky, James L Peugh, Lee A Denson, Jeffrey S Hyams, Debra Lobato, Neal S LeLeiko, Kevin A Hommel
Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis. Alimentary pharmacology & therapeutics 50 (8) (2019)
Jeffrey S Hyams, Marla Dubinsky, Joel Rosh, Frank M Ruemmele, Samantha F Eichner, Jen-Fue Maa, Andreas Lazar, Gabriela Alperovich, Nael M Mostafa, Anne M Robinson
The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn's disease: a post hoc analysis. Alimentary pharmacology & therapeutics 49 (2) (2018)